English
EspañolIAPO side-events at the 70th World Health Assembly
Biotherapeutics & the next 70 years: Delivering on their potential for patients globally
Date: 23 May 2017
Time: 12:00-14:00hrs
Location: International Red Cross and Red Crescent Museum (Espace Henry Dunant), Avenue de la Paix 17, 1202, Geneva
Co-hosted by IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) and IAPO, this event aims taking collaborative and coordinated actions to improve access to biotherapeutics by 2030 as a part of the Sustainable Development Goal 3 - Ensure healthy lives and promote well-being for all at all ages.
Please, register for the event here.
Displaced people with chronic conditions – How to tackle the pandemic on the move: Managing NCDs for refugee populations through Multistakeholder partnershipsDate: 24 May 2017
Time: 12:00-13:30hrs
Location: Musée Ariana, Avenue la Paix 10, 1202, Geneva
Co-hosted by IAPO, the Kenya Red Cross Society, Novartis, and Novo Nordisk, this event will debate the burden of noncommunicable diseases in displaced populations and the specific health challenges they face. It will call upon actors from all sectors to share experiences and ideas on how to address the unmet needs. Multi-stakeholder partnerships and innovative financing models are needed to cope with the situation at hand.
Please, register for the event here.
Access and care of patients with polychronic conditions: An expert dialogue meetingDate: 24 May 2017
Time: 12:00-14:30hrs
Venue: Restaurant Vieux Bois (Dunant & Ariana meeting rooms), Avenue de la Paix 12, 1202, Geneva
The moment individuals are diagnosed with a chronic condition, they face life-changing physical, mental and social consequences that affect not only themselves, but also family members, friends and caregivers. When that diagnosis extends to a second chronic condition—or a third, fourth, fifth or more—the burden on both the patient and society multiplies substantially. Patients who are polychronic, are those with two or more chronic conditions simultaneously. This is a global health challenge affecting developed and developing countries alike, breaking the rules of the global healthcare system, magnifying the complexity of treatment, exponentially increasing costs and, most importantly, taking a toll on individuals and families.
Co hosted by TEVA and IAPO, this event aims to convene experts on the issues of patients with polychronic conditions, aspiring to unite the health care, policy and patient communities to address siloes between sectors and align policy agendas; highlight the interconnections between the major global risks in the context of sustainable development goals 3 and the post-2015 development agenda, with particular focus on people suffering from polychronic conditions; and establish synergistic opportunities in polychronic, specifically highlighting ‘what works’ in the co-benefits approach to advance sustainable development and reducing risks and enhancing effective management of polychronic conditions
Addressing sepsis - the unrecognized number one cause of preventable deaths from infection
Date: 24 May 2017
Time: 12:00-14:30hrs
Location: Domain de Penthes, Chemin de l'Impératrice 18, 1292, Chambésy
The dialogue, co-hosted by the Global Sepsis Alliance (GSA), the German Ministry of Health and IAPO, will be in effort to support the recommendation of the WHO Executive Board to the 70th World Health Assembly to adopt a resolution on sepsis that urges member states to develop training for all health professionals on infection prevention and patient safety. It also aims to highlight and help in understanding that infections which may lead to sepsis can often be prevented through appropriate hygiene, access to vaccination programs, to improved sanitation and water availability.
Global heart health and the road to 2025: Supporting a heart healthy agenda for the age of longevityDate: 24 May 2017
Time: 18:30-20:00hrs
Venue: InterContinental Hotel, Chemin du Petit-Saconnex 7-9, Geneva
This event will serve as a platform to share new data from 'Global Heart Health: Evaluating Efforts to Promote Healthy Hearts', a comprehensive report and scorecard of country progress in heart health, created by The Economist Intelligence Unit. A panel of health and innovation experts will discuss where countries stand on the road to reducing premature mortality due to cardiovascular diseases by 2025. Experts will highlight the major challenges they face and discuss the available opportunities to unleash innovation in disease prevention, management and treatment in an ageing world. This event is co-hosted by the World Heart Federation, DEVEX and IAPO, and is supported by Novartis.
Please, register for the event here.
Safeguarding blood safety for the multi-transfused patientsDate: 26 May 2017
Time: 18:00-19:30hrs
Venue: UN Headquarters (Room IX), Avenue de la Paix 8-14 , 1211, Geneva
Organized by blood and blood product using patients' organizations Thalassaemia International Federation (TIF), IAPO, World Federation of Hemophilia (WFH), International Society of Blood Transfusion (ISBT), Worldwide Network for Blood & Marrow Transplantation (WBMT) and International Patient Organisation for Primary Immunodeficiencies (IPOPI), this event will focus on raising discussion on blood safety for the multi-transfused patients and the patient perspective on the principles of global consensus on donation and management of blood and blood products. Multi-transfused patients are exposed to more risks from infections and adverse immunological response after a mismatched blood transfusion than any other blood recipients. Giving blood is like giving medication and the Medication Without Harm-the 3rd Global Patient Safety Challenge offers some systemic issues we need to address to strengthen patient safety in blood donations and transfusions. The meeting will be held in the prestigious Salle IX next to the main debating chambers. Anyone can drop in, even the new Director General whoever he or she is!
